Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Picankibart (IBI112) Phase II trial in plaque psoriasis
NCT05003531Phase 2Completed
- Sponsor
- Innovent Biologics
- Start
- Sep 2021
- Primary completion
- Mar 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of picankibart in plaque psoriasis, sponsored by Innovent Biologics. Started Sep 2021; status: completed.
02
Drugs
picankibart
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT05003531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05003531.